(Q39742186)

14 September 2017

title

Development of a nomogram to predict probability of positive initial prostate biopsy among Japanese patients (English)

1 reference

14 September 2017

0 references

0 references

Hiroyoshi Suzuki

1

1 reference

14 September 2017

Akira Komiya

2

1 reference

14 September 2017

Naoto Kamiya

3

1 reference

14 September 2017

Takashi Imamoto

4

1 reference

14 September 2017

Koji Kawamura

5

1 reference

14 September 2017

Junichiro Miura

6

1 reference

14 September 2017

Noriyuki Suzuki

7

1 reference

14 September 2017

Hiroomi Nakatsu

8

1 reference

14 September 2017

Akira Hata

9

1 reference

14 September 2017

Tomohiko Ichikawa

10

1 reference

14 September 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

14 September 2017

1 reference

14 September 2017

volume

67

1 reference

14 September 2017

issue

1

1 reference

14 September 2017

page(s)

131-136

1 reference

Prostate cancer incidence and mortality in the United States and the United Kingdom

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.07.040

Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.07.040

Radical prostatectomy versus watchful waiting in early prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.07.040

Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.07.040

Clinical usefulness of serum antip53 antibodies for prostate cancer detection: a comparative study with prostate specific antigen parameters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.07.040

An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: results on 4298 cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.07.040

Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.07.040

Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.07.040

Nomograms and instruments for the initial prostate evaluation: the ability to estimate the likelihood of identifying prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.07.040

Novel artificial neural network for early detection of prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.07.040

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.07.040

Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels ≤ 10 ng/mL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.07.040

A Nomogram For Predicting a Positive Repeat Prostate Biopsy in Patients With a Previous Negative Biopsy Session

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.07.040

Statistical prediction models, artificial neural networks, and the sophism "I am a patient, not a statistic".

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.07.040

The incidence of prostate cancer in men with prostate specific antigen greater than 4.0 ng/ml: a randomized study of 6 versus 12 core transperineal prostate biopsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.07.040

10.1016/J.UROLOGY.2005.07.040

7 January 2021

Identifiers

DOI

1 reference

14 September 2017

1 reference